概括
复合物缩物有效治疗因子VIII抑制剂患者的急性出血. 在血友病患者中,Proplex的持续使用降低了抑制剂水平,恢复了因子VIII的反应能力.
科学领域:
- 血液学 血液学 血液学
- 凝血障碍 凝血障碍 凝血障碍
- 免疫学 免疫学 免疫学
背景情况:
- 第八因子抑制剂使血友病治疗复杂化,导致急性出血发作.
- 目前,因子VIII抑制剂患者的治疗选择有限.
- 血红素复合物缩剂 (PCCs) 用于在血友病中控制出血.
研究的目的:
- 评估前热血素复合物缩剂在治疗因子VIII抑制剂患者急性出血中的疗效.
- 评估PCCs对抑制剂水平和XVIII因子反应能力的影响.
主要方法:
- 对11名血友病患者和2名非血友病患者使用因子VIII抑制剂的回顾性分析.
- 治疗急性出血发作时使用前热血素复合物缩剂 (Proplex).
- 在缩剂使用期间监测抑制剂水平和XVIII因子反应.
主要成果:
- PCCs在管理急性出血发作方面是有效的.
- 持续使用Proplex导致几名血友病患者的抑制剂水平下降.
- 一名血友病患者在长期PCC治疗后对因子VIII治疗产生反应.
结论:
- 复合物缩物是一种可行的治疗选择,用于患有第八因子抑制剂的患者.
- 作用机制可能涉及激活因子或体内XA因子的产生.
- PCCs提供了一个有效的替代品,直到高强度激活产品变得广泛可用.
相关概念视频
Anticoagulant Drugs: Low-Molecular-Weight Heparins
Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
Anticoagulant Drugs: Vitamin K Antagonists and Direct Oral Anticoagulants
Oral anticoagulants are vital tools in preventing and treating blood clotting disorders. This diverse class of medications can be categorized as vitamin K antagonists, exemplified by warfarin, and direct thrombin inhibitors (DTIs), such as dabigatran, as well as factor Xa inhibitors, including rivaroxaban.
Warfarin, a prominent vitamin K antagonist family member, exerts its effect by inhibiting the enzyme VKORC1 (vitamin K epoxide reductase complex 1). By hindering this enzyme, warfarin...
Warfarin, a prominent vitamin K antagonist family member, exerts its effect by inhibiting the enzyme VKORC1 (vitamin K epoxide reductase complex 1). By hindering this enzyme, warfarin...
Disorders of Hemostasis
Hemostasis, the process that stops bleeding after a blood vessel injury, is crucial for maintaining the integrity of the circulatory system. However, disorders of hemostasis can disrupt this delicate balance, leading to either excessive clotting or bleeding. These disorders can be broadly classified into thromboembolic disorders and bleeding disorders.
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.
Venous Thrombosis III: Interprofessional Care
Venous thrombosis requires effective prevention and treatment strategies to improve patient outcomes and reduce potential complications.Prevention StrategiesHealthcare providers must prioritize preventing venous thromboembolism (VTE) for all adult patients upon admission. Interventions depend on bleeding and thrombosis risk, medical history, current medications, diagnoses, planned procedures, and patient preferences. Patients on bed rest should change positions every two hours and, if not...
Venous Thrombosis IV: Nursing Management
Nursing management begins with a thorough assessment of the patient's health history. Key factors include trauma to veins, peripherally inserted central catheters, varicose veins, recent pregnancy or childbirth, surgery, bacteremia, prolonged bed rest, atrial fibrillation, COPD, heart failure, cancer, coagulation disorders, myocardial infarction, spinal cord injury, stroke, prolonged travel, recent bone fractures, and dehydration. Review medication intake, particularly oral contraceptives,...
Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care
Diagnosing Pulmonary EmbolismDiagnosing pulmonary embolism (PE) involves clinical assessment and advanced imaging tests. The preferred diagnostic tool is the spiral (helical) CT scan or CT angiography (CTA), which uses intravenous contrast media to visualize the pulmonary vasculature and identify emboli.A ventilation-perfusion (V/Q) scan is an alternative for patients unable to receive contrast media. This scan includes both perfusion and ventilation scanning. Perfusion scanning involves...


